This report contains market size and forecasts of CRISPR Gene Testing and Diagnostics in Global, including the following market information:
Global CRISPR Gene Testing and Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CRISPR Gene Testing and Diagnostics market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Animals Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CRISPR Gene Testing and Diagnostics include 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioM?rieux and Bio-Rad Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the CRISPR Gene Testing and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR Gene Testing and Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, by Type, 2021 (%)
Animals
Plants
Pathogens
Others
Global CRISPR Gene Testing and Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, by Application, 2021 (%)
Medical Industry
Agriculture
Others
Global CRISPR Gene Testing and Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR Gene Testing and Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CRISPR Gene Testing and Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioM?rieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 CRISPR Gene Testing and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR Gene Testing and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR Gene Testing and Diagnostics Overall Market Size
2.1 Global CRISPR Gene Testing and Diagnostics Market Size: 2021 VS 2028
2.2 Global CRISPR Gene Testing and Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR Gene Testing and Diagnostics Players in Global Market
3.2 Top Global CRISPR Gene Testing and Diagnostics Companies Ranked by Revenue
3.3 Global CRISPR Gene Testing and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 CRISPR Gene Testing and Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies CRISPR Gene Testing and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 CRISPR Gene Testing and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global CRISPR Gene Testing and Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Animals
4.1.3 Plants
4.1.4 Pathogens
4.1.5 Others
4.2 By Type - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global CRISPR Gene Testing and Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global CRISPR Gene Testing and Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CRISPR Gene Testing and Diagnostics Market Size, 2021 & 2028
5.1.2 Medical Industry
5.1.3 Agriculture
5.1.4 Others
5.2 By Application - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global CRISPR Gene Testing and Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global CRISPR Gene Testing and Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global CRISPR Gene Testing and Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global CRISPR Gene Testing and Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global CRISPR Gene Testing and Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CRISPR Gene Testing and Diagnostics Revenue, 2017-2028
6.3.2 US CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.3.3 Canada CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.3.4 Mexico CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, 2017-2028
6.4.2 Germany CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4.3 France CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4.4 U.K. CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4.5 Italy CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4.6 Russia CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.4.8 Benelux CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, 2017-2028
6.5.2 China CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.5.3 Japan CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.5.4 South Korea CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.5.6 India CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CRISPR Gene Testing and Diagnostics Revenue, 2017-2028
6.6.2 Brazil CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.6.3 Argentina CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, 2017-2028
6.7.2 Turkey CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.7.3 Israel CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
6.7.5 UAE CRISPR Gene Testing and Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 10x Genomics
7.1.1 10x Genomics Corporate Summary
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.1.4 10x Genomics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.1.5 10x Genomics Key News
7.2 Aelian Biotechnology
7.2.1 Aelian Biotechnology Corporate Summary
7.2.2 Aelian Biotechnology Business Overview
7.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Major Product Offerings
7.2.4 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Aelian Biotechnology Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Major Product Offerings
7.3.4 Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Agilent Technologies Key News
7.4 Axxam
7.4.1 Axxam Corporate Summary
7.4.2 Axxam Business Overview
7.4.3 Axxam CRISPR Gene Testing and Diagnostics Major Product Offerings
7.4.4 Axxam CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Axxam Key News
7.5 Beckman Coulter
7.5.1 Beckman Coulter Corporate Summary
7.5.2 Beckman Coulter Business Overview
7.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Major Product Offerings
7.5.4 Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Beckman Coulter Key News
7.6 Becton, Dickinson and Company
7.6.1 Becton, Dickinson and Company Corporate Summary
7.6.2 Becton, Dickinson and Company Business Overview
7.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Major Product Offerings
7.6.4 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Becton, Dickinson and Company Key News
7.7 Binx Health
7.7.1 Binx Health Corporate Summary
7.7.2 Binx Health Business Overview
7.7.3 Binx Health CRISPR Gene Testing and Diagnostics Major Product Offerings
7.7.4 Binx Health CRISPR Gene Testing and Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Binx Health Key News
7.8 bioM